Skip to main content
. 2017 May 8;8(30):49451–49469. doi: 10.18632/oncotarget.17706

Figure 4. Effects of miR-660-5p overexpression on K562 cells' response to TKIs.

Figure 4

(A) Expression levels of miR-660-5p 24 hours after the last nucleofection as evaluated by qRT-PCR. Data are reported as RQ mean ± S.E.M of 3 independent experiments. The results are expressed as mean values ± SEM (B) Normalized MIF of intracellular p-CrkL levels in K562 cells after miR-660-5p overexpression. pCRKL MIF of the Neg CTR mimic untreated control was set to 1 to compare K562 before and after treatment with IM. The results are expressed as mean values ± SEM (n = 3) *p < 0.05, **p < 0.01. Results of Annexin V/PI staining on K562 cells after 24 h (C) and 48 h (D) of IM treatment (mean ± SEM; n = 3). Representative dot plots for flow cytometry detection of Annexin V and PI staining at 24 h and 48 h after treatment are shown (E) i: Neg CTR mimic NT, ii: Neg CTR mimic IM 1 μM, iii: miR-660-5p mimic NT, iv: miR-660-5p mimic IM 1 μM, v: Neg CTR mimic NT, vi: Neg CTR mimic IM 0,4 μM, vii: miR-660-5p mimic NT, viii: miR-660-5p mimic IM 0,4 μM). (F) Results of Annexin V/PI staining on K562 cells after 24h of 10nM Ponatinib or 100nM Dasatinib treatment (mean ± SEM; n = 3) *p < 0.05, **p < 0.01. Abbreviations: RQ, Relative Quantity; MIF indicates mean fluorescence intensity; IM, imatinib mesylate; NT, Not Treated; 24 h, 24 hours; 48 h, 48 hours; PI, Propidium Iodide.